TABLE 2

Baseline Patient Characteristics

CharacteristicData
n116
Age (y)68.0 (49.0–84.0)
Weight (kg)82.5 (50.0–122.0)
Height (cm)180.0 (155.0–198.0)
PSA level (ng/mL)9.7 (0.5–2,790.0)
Gleason score (cumulative)7 (6–9)
Scan indication81/116 (69.8%)
 Staging
 Recurrent PCa25/116 (21.6%)
 mCRPC10/116 (8.6%)
Therapy before PET34/116 (29.3%)
  • Qualitative data are number and percentage; continuous data are median and range.